First Header Logo Second Header Logo

Connection

Thomas Wierzba to Vibrio cholerae

This is a "connection" page, showing publications Thomas Wierzba has written about Vibrio cholerae.
Connection Strength

0.901
  1. Kanungo S, Desai SN, Saha J, Nandy RK, Sinha A, Kim DR, Bannerjee B, Manna B, Yang JS, Ali M, Sur D, Wierzba TF. An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India. PLoS Negl Trop Dis. 2015 May; 9(5):e0003809.
    View in: PubMed
    Score: 0.614
  2. Kanungo S, Desai SN, Nandy RK, Bhattacharya MK, Kim DR, Sinha A, Mahapatra T, Yang JS, Lopez AL, Manna B, Bannerjee B, Ali M, Dhingra MS, Chandra AM, Clemens JD, Sur D, Wierzba TF. Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. PLoS Negl Trop Dis. 2015 Mar; 9(3):e0003574.
    View in: PubMed
    Score: 0.151
  3. You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, Nair GB, Bhattacharya SK, Convertino M, Deen JL, Lopez AL, Wierzba TF, Clemens J, Sur D. Risk map of cholera infection for vaccine deployment: the eastern Kolkata case. PLoS One. 2013; 8(8):e71173.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.